🇺🇸 FDA
Patent

US 6692763

Methods for treating postmenopausal women using ultra-low doses of estrogen

expired A61KA61K31/56A61K31/565

Quick answer

US patent 6692763 (Methods for treating postmenopausal women using ultra-low doses of estrogen) held by The Regents of the University of California expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/56, A61K31/565, A61K9/7023, A61P